NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Wi R, Chung YC, Jin BK. Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease. Journal of Immunology Research. 2020: 5093493. PMID 33062722 DOI: 10.1155/2020/5093493   
2020 Ramírez-Jarquín UN, Shahani N, Pryor W, Usiello A, Subramaniam S. The mammalian target of rapamycin (mTOR) kinase mediates haloperidol-induced cataleptic behavior. Translational Psychiatry. 10: 336. PMID 33009372 DOI: 10.1038/s41398-020-01014-x   
2020 Song MK, Lee JH, Kim J, Kim JH, Hwang S, Kim YS, Kim YJ. Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model. Neuroscience Letters. 135425. PMID 33075422 DOI: 10.1016/j.neulet.2020.135425   
2020 Fernández-García S, Conde-Berriozabal S, García-García E, Gort-Paniello C, Bernal-Casas D, García-Díaz Barriga G, López-Gil J, Muñoz-Moreno E, Soria G, Campa L, Artigas F, Rodríguez MJ, Alberch J, Masana M. M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington's disease. Elife. 9. PMID 33016873 DOI: 10.7554/eLife.57017   
2020 Requejo C, López-de-Ipiña K, Ruiz-Ortega JÁ, Fernández E, Calvo PM, Morera-Herreras T, Miguelez C, Cardona-Grifoll L, Cepeda H, Ugedo L, Lafuente JV. Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson's Disease: Exploring Prodromal Biomarkers. Frontiers in Neuroscience. 14: 590029. PMID 33154717 DOI: 10.3389/fnins.2020.590029   
2020 Sun J, Li H, Jin Y, Yu J, Mao S, Su KP, Ling Z, Liu J. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway. Brain, Behavior, and Immunity. PMID 33148438 DOI: 10.1016/j.bbi.2020.10.014   
2020 Ou Z, Zhou Y, Wang L, Xue L, Zheng J, Chen L, Tong Q. NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP-Treated NLRP3 Knockout Mice. Molecular Neurobiology. PMID 33169332 DOI: 10.1007/s12035-020-02198-5   
2020 Park H, Chang KA. Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson's Disease Mouse Model. International Journal of Molecular Sciences. 21. PMID 33143234 DOI: 10.3390/ijms21218129   
2020 Antunes MS, Ladd FVL, Ladd AABL, Moreira AL, Boeira SP, Cattelan Souza L. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis. Metabolic Brain Disease. PMID 33057922 DOI: 10.1007/s11011-020-00618-y   
2020 Moreira CG, Morawska MM, Baumann A, Masneuf S, Linnebank M, Sommerauer M, Landolt HP, Noain D, Baumann CR. Improved functional and histochemical outcomes in l-DOPA plus tolcapone treated VMAT2-deficient mice. Neuropharmacology. 181: 108353. PMID 33038358 DOI: 10.1016/j.neuropharm.2020.108353   
2020 Li DD, Wang GQ, Wu Q, Shi JS, Zhang F. Dendrobium nobile lindl alkaloid attenuates 6-OHDA-induced dopamine neurotoxicity. Biotechnology and Applied Biochemistry. PMID 33146428 DOI: 10.1002/bab.2071   
2020 Altwal F, Moon C, West AR, Steiner H. The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA-Induced Gene Regulation in Striatal Projection Neurons and Associated Dyskinesia in an Animal Model of Parkinson's Disease. Cells. 9. PMID 33050305 DOI: 10.3390/cells9102265   
2020 Sun Y, Lu XJ, Fu X, Zhang Y, Zhan Y, Liu J, Zhao L, Xia CL. Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease. Molecular and Cellular Biochemistry. PMID 33070275 DOI: 10.1007/s11010-020-03931-3   
2020 Favier M, Janickova H, Justo D, Kljakic O, Runtz L, Natsheh JY, Pascoal TA, Germann J, Gallino D, Kang JI, Meng XQ, Antinora C, Raulic S, Jacobsen JP, Moquin L, et al. Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eating. The Journal of Clinical Investigation. PMID 33164988 DOI: 10.1172/JCI138532   
2020 Patel C, Meadowcroft MD, Zagon IS, McLaughlin PJ. [Met]-enkephalin preserves diffusion metrics in EAE mice. Brain Research Bulletin. 165: 246-252. PMID 33141073 DOI: 10.1016/j.brainresbull.2020.10.015   
2020 Wang M, Wan C, He T, Han C, Zhu K, Waddington JL, Zhen X. Sigma-1 receptor regulates mitophagy in dopaminergic neurons and contributes to dopaminergic protection. Neuropharmacology. 108360. PMID 33122030 DOI: 10.1016/j.neuropharm.2020.108360   
2020 Fletcher EJR, Finlay CJ, Amor Lopez A, Crum WR, Vernon AC, Duty S. Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats. Frontiers in Neuroscience. 14: 567222. PMID 33041762 DOI: 10.3389/fnins.2020.567222   
2020 Kesh S, Kannan RR, Sivaji K, Balakrishnan A. Hesperidin downregulates kinases lrrk2 and gsk3β in a 6-OHDA induced Parkinson's disease model. Neuroscience Letters. 135426. PMID 33075420 DOI: 10.1016/j.neulet.2020.135426   
2020 Ribeiro MJ, Vercouillie J, Arlicot N, Tauber C, Gissot V, Mondon K, Barantin L, Cottier JP, Maia S, Deloye JB, Emond P, Guilloteau D. Usefulness of PET With [F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment. Frontiers in Neurology. 11: 754. PMID 32973645 DOI: 10.3389/fneur.2020.00754   
2020 Birolini G, Valenza M, Di Paolo E, Vezzoli E, Talpo F, Maniezzi C, Caccia C, Leoni V, Taroni F, Bocchi VD, Conforti P, Sogne E, Petricca L, Cariulo C, Verani M, et al. Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington's disease mice. Embo Molecular Medicine. e12519. PMID 32959531 DOI: 10.15252/emmm.202012519   
2020 Saleem U, Chauhdary Z, Raza Z, Shah S, Rahman MU, Zaib P, Ahmad B. Anti-Parkinson's Activity of via Modulation of AChE, α-Synuclein, TNF-α, and IL-1β. Acs Omega. 5: 25216-25227. PMID 33043200 DOI: 10.1021/acsomega.0c03375   
2020 Wong FY, Gogos A, Hale N, Ingelse S, Brew N, Shepherd KL, Van Den Buuse M, Walker DW. Impact of hypoxia-ischaemia and dopamine treatment on dopamine receptor binding density in the preterm fetal sheep brain. Journal of Applied Physiology (Bethesda, Md. : 1985). PMID 33054660 DOI: 10.1152/japplphysiol.00677.2020   
2020 Wang Y, Wei N, Li X. Preclinical Evidence and Possible Mechanisms of Baicalein for Rats and Mice With Parkinson's Disease: A Systematic Review and Meta-Analysis. Frontiers in Aging Neuroscience. 12: 277. PMID 33101006 DOI: 10.3389/fnagi.2020.00277   
2020 Xu Q, Yang S, Wu F, Lin Y, Zhong J, Tang L, Hu X, Cai J. Congrong Shujing Granule-Induced GRP78 Expression Reduced Endoplasmic Reticulum Stress and Neuronal Apoptosis in the Midbrain in a Parkinson's Disease Rat Model. Evidence-Based Complementary and Alternative Medicine : Ecam. 2020: 4796236. PMID 33062012 DOI: 10.1155/2020/4796236   
2020 de Almeida GRL, Szczepanik JC, Selhorst I, Schmitz AE, Dos Santos B, Cunha MP, Heinrich IA, de Paula GC, De Bem AF, Leal RB, Dafre AL. Methylglyoxal-Mediated Dopamine Depletion, Working Memory Deficit, and Depression-Like Behavior Are Prevented by a Dopamine/Noradrenaline Reuptake Inhibitor. Molecular Neurobiology. PMID 33011857 DOI: 10.1007/s12035-020-02146-3   
2020 Conway JA, Ince S, Black S, Kramer ER. GDNF/RET signaling in dopamine neurons in vivo Cell and Tissue Research. 382: 135-146. PMID 32870383 DOI: 10.1007/s00441-020-03268-9   
2020 Rodrigues FS, França AP, Broetto N, Furian AF, Oliveira MS, Santos ARS, Royes LFF, Fighera MR. Sustained glial reactivity induced by glutaric acid may be the trigger to learning delay in early and late phases of development: Involvement of p75 receptor and protection by N-acetylcysteine. Brain Research. 1749: 147145. PMID 33035499 DOI: 10.1016/j.brainres.2020.147145   
2020 Wilson MW, Shu L, Hinkovska-Galcheva V, Jin Y, Rajeswaran W, Abe A, Zhao T, Luo R, Wang L, Wen B, Liou B, Fannin V, Sun D, Sun Y, Shayman JA, et al. Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3. Acs Chemical Neuroscience. PMID 33035424 DOI: 10.1021/acschemneuro.0c00558   
2020 Liu Z, Cheung HH. Stem Cell-Based Therapies for Parkinson Disease. International Journal of Molecular Sciences. 21. PMID 33137927 DOI: 10.3390/ijms21218060   
2020 Schneider JS, Marshall CA, Keibel L, Snyder NW, Hill MP, Brotchie JM, Johnston TH, Waterhouse BD, Kortagere S. A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease. Experimental Neurology. 335: 113514. PMID 33141071 DOI: 10.1016/j.expneurol.2020.113514   
2020 Mehkari Z, Mohammed L, Javed M, Althwanay A, Ahsan F, Oliveri F, Goud HK, Rutkofsky IH. Manganese, a Likely Cause of 'Parkinson's in Cirrhosis', a Unique Clinical Entity of Acquired Hepatocerebral Degeneration. Cureus. 12: e10448. PMID 33072457 DOI: 10.7759/cureus.10448   
2020 Goncalves DF, Guzman MS, Gros R, Massensini AR, Bartha R, Prado VF, Prado MAM. Striatal Acetylcholine Helps to Preserve Functional Outcomes in a Mouse Model of Stroke. Asn Neuro. 12: 1759091420961612. PMID 32967452 DOI: 10.1177/1759091420961612   
2020 Krum BN, Martins AC, Queirós L, Ferrer B, Milne GL, Soares FAA, Fachinetto R, Aschner M. Haloperidol Interactions with the dop-3 Receptor in Caenorhabditis elegans. Molecular Neurobiology. PMID 32935232 DOI: 10.1007/s12035-020-02124-9   
2020 Fu JF, Matarazzo M, McKenzie J, Neilson N, Vafai N, Dinelle K, Felicio AC, McKeown MJ, Stoessl AJ, Sossi V. Serotonergic System Impacts Levodopa Response in Early Parkinson's and Future Risk of Dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33090574 DOI: 10.1002/mds.28340   
2020 Bittencourt A, Brum PO, Ribeiro CT, Gasparotto J, Bortolin RC, de Vargas AR, Heimfarth L, de Almeida RF, Moreira JCF, de Oliveira J, Gelain DP. High fat diet-induced obesity causes a reduction in brain tyrosine hydroxylase levels and non-motor features in rats through metabolic dysfunction, neuroinflammation and oxidative stress. Nutritional Neuroscience. 1-15. PMID 33078695 DOI: 10.1080/1028415X.2020.1831261   
2020 Morello F, Voikar V, Parkkinen P, Panhelainen A, Rosenholm M, Makkonen A, Rantamäki T, Piepponen P, Aitta-Aho T, Partanen J. ADHD-like behaviors caused by inactivation of a transcription factor controlling the balance of inhibitory and excitatory neuron development in the mouse anterior brainstem. Translational Psychiatry. 10: 357. PMID 33087695 DOI: 10.1038/s41398-020-01033-8   
2020 Shen Y, Yu WB, Shen B, Dong H, Zhao J, Tang YL, Fan Y, Yang YF, Sun YM, Luo SS, Chen C, Liu FT, Wu JJ, Xiao BG, Yu H, et al. Propagated α-synucleinopathy recapitulates REM sleep behaviour disorder followed by parkinsonian phenotypes in mice. Brain : a Journal of Neurology. PMID 33170925 DOI: 10.1093/brain/awaa283   
2020 Seo J, Won J, Kim K, Park J, Yeo HG, Kim YG, Baek SH, Lee H, Jeon CY, Choi WS, Lee S, Kim KJ, Park SH, Son Y, Jeong KJ, et al. Impaired Hand Dexterity Function in a Non-human Primate Model with Chronic Parkinson's Disease. Experimental Neurobiology. 29: 376-388. PMID 33154199 DOI: 10.5607/en20040   
2020 Aguirre-Vidal Y, Rodríguez-Ramos C, Mendieta L, Romero-Sánchez HA, Garza-Mouriño G, Benítez-Díaz Mirón MI, Castellanos-Páez ME, Pérez-Ramos J, Godínez-Chaparro B. Synergistic antiallodynic and antihyperalgesic interaction between L-DOPA and celecoxib in parkinsonian rats is mediated by NO-cGMP-ATP-sensitive K channel. European Journal of Pharmacology. 889: 173537. PMID 32971091 DOI: 10.1016/j.ejphar.2020.173537   
2020 Artaud F, Lee PC, Mangone G, Vidailhet M, Corvol JC, Elbaz A. Longitudinal association between dopamine agonists and weight in Parkinson's disease. Parkinsonism & Related Disorders. 80: 158-164. PMID 33011605 DOI: 10.1016/j.parkreldis.2020.09.037   
2020 Beauchamp LC, Villemagne VL, Finkelstein DI, Doré V, Bush AI, Barnham KJ, Rowe CC. Reduced striatal vesicular monoamine transporter 2 in REM sleep behavior disorder: imaging prodromal parkinsonism. Scientific Reports. 10: 17631. PMID 33097764 DOI: 10.1038/s41598-020-74495-x   
2020 Girgis RR, Slifstein M, Brucato G, Kegeles LS, Colibazzi T, Lieberman JA, Abi-Dargham A. Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [C]-(+)-PHNO PET with methylphenidate challenge study. Molecular Psychiatry. PMID 33154566 DOI: 10.1038/s41380-020-00934-w   
2020 Li Y, Jiao Q, Du X, Jiang H. Sirt1/FoxO1-Associated MAO-A Upregulation Promotes Depressive-Like Behavior in Transgenic Mice Expressing Human A53T α-Synuclein. Acs Chemical Neuroscience. PMID 33155799 DOI: 10.1021/acschemneuro.0c00628   
2020 Pingale T, Gupta GL. Current and emerging therapeutic targets for Parkinson's disease. Metabolic Brain Disease. PMID 33090348 DOI: 10.1007/s11011-020-00636-w   
2020 Burgos-Aguilar C, Ferris MJ, Sexton LL, Sun H, Xiao R, Chen R, Childers SR, Howlett AC. Metabotropic glutamate 2,3 receptor stimulation desensitizes agonist activation of G-protein signaling and alters transcription regulators in mesocorticolimbic brain regions. Synapse (New York, N.Y.). e22190. PMID 33025628 DOI: 10.1002/syn.22190   
2020 Lopes GO, Martins Ferreira MK, Davis L, Bittencourt LO, Bragança Aragão WA, Dionizio A, Rabelo Buzalaf MA, Crespo-Lopez ME, Maia CSF, Lima RR. Effects of Fluoride Long-Term Exposure over the Cerebellum: Global Proteomic Profile, Oxidative Biochemistry, Cell Density, and Motor Behavior Evaluation. International Journal of Molecular Sciences. 21. PMID 33023249 DOI: 10.3390/ijms21197297   
2020 Ali AM, Kunugi H. Apitherapy for Parkinson's Disease: A Focus on the Effects of Propolis and Royal Jelly. Oxidative Medicine and Cellular Longevity. 2020: 1727142. PMID 33123309 DOI: 10.1155/2020/1727142   
2020 Rauschenberger L, Knorr S, Volkmann J, Ip CW. Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia. Journal of Visualized Experiments : Jove. PMID 32986028 DOI: 10.3791/61635   
2020 Booth S, Ramadan A, Zhang D, Lu L, Kirouac G, Jackson MF, Anderson C, Ko JH. The Vasomotor Response to Dopamine Is Altered in the Rat Model of L-dopa-Induced Dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33135810 DOI: 10.1002/mds.28357   
2020 Shrader SH, Tong YG, Duff MB, Freedman JH, Song ZH. Involvement of dopamine receptor in the actions of non-psychoactive phytocannabinoids. Biochemical and Biophysical Research Communications. PMID 33097185 DOI: 10.1016/j.bbrc.2020.10.021